7:25 am
Thu November 6, 2014

Perrigo Announces Plans to Acquire Belgian Company

Credit Perrigo/Wikimedia Commons

Perrigo says it is acquiring a Belgium-based over the counter  healthcare company. 

Read more
6:32 am
Wed July 16, 2014

No Word on Perrigo Seeking a Buyer

Lead in text: 
The company offered no comment on a report in an Israeli business publication
  • Source: Mlive
  • | Via: Kalamazoo Gazette
ALLEGAN, MI - Shares of Perrigo Co. PLC gained more than 9 percent Monday in heavy trading as investors reacted to a report that the store-brand products maker may be looking for a buyer. Israeli business publication Globes reported that Perrigo has hired an investment bank "to consider its sale through a merger with a major pharmaceutical firm."
8:07 pm
Mon March 3, 2014

Perrigo Acquires New Products to Sell Overseas

Lead in text: 
The products are expected to generate at least $20-million in annual revenue
  • Source: Mlive
  • | Via: Kalamazoo Gazette
ALLEGAN, MI -- Perrigo Co. is expanding its activities overseas with the acquisition of a collection of over-the-counter products sold in Australia and New Zealand and with transactions that modify its involvement with a neuropsychiatric drug being developed in Ireland.
7:19 pm
Mon July 29, 2013

Governor Snyder's office "disappointed" Perrigo to become Irish company

Lead in text: 
Perrigo announced acquisition of Ireland's Elan Pharmaceuticals on Monday
  • Source: Mlive
  • | Via: Kalamazoo Gazette
ALLEGAN, MI - Gov. Rick Snyder's office is disappointed Perrigo Co. will become an Irish company but is not ignoring company plans to continue investing in West Michigan.
7:15 am
Mon July 29, 2013

Perrigo to acquire Irish pharmaceutical company

Lead in text: 
Allegan-based company says deal will allow for international expansion and diversifying global business
Allegan-based generic drug manufacturer Perrigo announced this morning that it agreed to acquire Irish pharmaceutical maker Elan Corp. PLC in a cash-and-stock transaction valued at $8.6 billion.
Read More: